Advances in immunobiology knowledge as well as in cell culture processes that generate
large numbers of purified and functionally mature dendritic cells (DCs) have raised the …

If one envisions dendritic cells (DCs) as nature's adjuvant, then it is easy to predict that they
would be advantageous for cancer immunotherapy. Advances in culture processes that …

Dendritic cells (DCs) are specialized immunostimulatory cells involved in the induction and
regulation of immune responses. The feasibility of large-scale ex vivo generation of DCs …

There has been enormous progress this past decade in the understanding of the biology of
dendritic cells (DCs) along with increasing attention for the development of novel dendritic …

Since their discovery, there has been significant progress in the understanding of dendritic
cell (DC) biology. Their capacity for priming an immune response against pathogens and …

Cancer immunotherapy seeks to mobilize a patient's immune system for therapeutic benefit.
It can be passive, that is, transfer of immune effector cells (T cells) or proteins (antibodies), or …

Despite initial enthusiasm, dendritic cell (DC)‐based anti‐cancer vaccines have yet to live
up to their promise as one of the best hopes for generating effective anti‐tumor immunity …

Tumor growth is controlled by natural antitumor immune responses alone or by augmented
immune reactivity resulting from different forms of immunotherapy, which has demonstrated …

Immunotherapy with tumor-associated antigen-pulsed, ex vivo-generated dendritic cells
(DCs) is a promising approach for the treatment of cancer that has shown efficacy in animal …

Dendritic cell-based immunotherapy is a promising strategy against cancer that appears to
be feasible, safe and to induce potent tumor-specific immune responses. The use of …